International Journal of Clinical Research

Objective: To analyze the value of intensive insulin pump therapy in newly treated patients with type 2 diabetes. Methods: 106 cases of newly-treated type 2 diabetes patients treated in our hospital from May 2019 to May 2020 were selected for a comprehensive analysis. The diagnosis and treatment data of all patients were completely preserved. The study grouping method was convenient sampling method, and 53 patients were selected. Included in the reference group and received intensive subcutaneous injection of insulin. The remaining 53 patients were included in the study group and received intensive insulin pump treatment. The clinical efficacy, blood sugar level, β-cell function, and treatment status of each group were compared. Results: The total clinical effective rate of the study group was 94.34%, which was significantly higher than that of the reference group (81.13%), P＜0.05; the HbAIC, FPG and 2hPG of the study group after treatment were significantly lower than those of the reference group, P＜0.05; treatment in the study group After HOMA-IR level was significantly lower than that of the reference group, HOMA-β level was significantly higher than that of the reference group, P<0.05; the incidence of hypoglycemia in the study group was 1.89%, which was significantly lower than that of the reference group, P<0.05; the blood glucose of the study group reached the standard The time was significantly earlier than that of the reference group, and the daily insulin consumption was significantly less than that of the reference group, P<0.05. Conclusion: Intensive insulin pump therapy for newly-treated patients with type 2 diabetes has a definite effect, which can significantly improve blood glucose levels and β-cell function, and also It can reduce the daily consumption of insulin, prevent hypoglycemia events, and has ideal clinical application value.

Insulin Pump; Intensive Treatment; Initial Treatment Of Type 2 Diabetes; Application Value